Loading
Latest filing published 20 Sept 2022 for Cardiff Oncology, Inc., €24k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lale White is a declared insider of Cardiff Oncology, Inc., with filings sourced from SEC (Form 4). Between 5 July 2022 and 19 September 2022, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 1 purchase, €24k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise.
Most recently, on 20 September 2022, the filings show an open-market purchase worth €24k in Cardiff Oncology, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations